IMATINIB MESYLATE | N021588 | NOVARTIS PHARMACEUTICALS CORP
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Novartis Pharmaceuticals Corporation et al v. Wockhardt Bio AG et al 2 patentsANDA 208429imatinib mesylate | D. Del. | 2016-01-26 | Terminated 2016-12-20 | — |
Novartis Pharmaceuticals Corporation et al v. Shilpa Medicare Limited 2 patentsANDA 208302imatinib mesylate | D. Del. | 2015-11-30 | Terminated 2016-07-27 | — |
Novartis Pharmaceuticals Corporation et al v. Natco Pharma Ltd. 2 patentsANDA 207818imatinib mesylate | D. Del. | 2015-10-28 | Terminated 2017-01-04 | — |
Novartis Pharmaceuticals Corporation et al v. Roxane Laboratories, Inc. 2 patentsANDA 207586imatinib mesylate | D. Del. | 2015-10-09 | Terminated 2017-04-05 | — |
Novartis Pharmaceuticals Corporation et al v. Ranbaxy Inc. et al 2 patentsANDA 206723imatinib mesylate | D. Del. | 2014-12-29 | Terminated 2015-10-21 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.